Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial is a paper indexed in PICO Portal from OpenAlex.
How many citations does Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial have?
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial has 312 citations in the OpenAlex counts PICO Portal stores.
When was Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial published?
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial has 2020 year in the PICO Portal index.
What is the open-access status of Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial?
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial has hybrid oa status in the PICO Portal index.
What is the DOI of Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial?
The DOI for Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial is on the source record.
What is the PMID of Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial?
The PMID for Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial is on the source record.
What is the OpenAlex record for Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial?
The OpenAlex for Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial is on the source record.